Alicia Secor Email

President & CEO . Atalanta Therapeutics

Current Roles

Employees:
70
Revenue:
$5.4M
About
We are a biotechnology company pioneering new treatment options for neurodegenerative diseases by utilizing our proprietary RNA interference platform. We were founded by Anastasia Khvorova, Ph.D., Craig Mello, Ph.D., and Neil Aronin, M.D., of the RNA Therapeutics Institute at the University of Massachusetts Medical School, with a Series A funding exclusively by F-Prime Capital. We are headquartered in Boston, Mass.
Atalanta Therapeutics Address
51 Sleeper Street
Boston, MA
United States
Atalanta Therapeutics Email

Past Companies

Atalanta TherapeuticsPresident & CEO
Orchard TherapeuticsMember Board Of Directors
Foundation For Prader-Willi ResearchBoard Member